Artikel ; Online: Utility of short-interval follow-up mammography after a benign-concordant stereotactic breast biopsy result.
2018 Band 42, Seite(n) 50–53
Abstract: Background: There is currently no clear consensus recommendation for the use of short-interval follow-up mammography after a benign-concordant breast biopsy (BCBB), and practice patterns vary widely. The objectives of this study were to evaluate whether ...
Abstract | Background: There is currently no clear consensus recommendation for the use of short-interval follow-up mammography after a benign-concordant breast biopsy (BCBB), and practice patterns vary widely. The objectives of this study were to evaluate whether a short-interval follow-up mammogram provided clinical utility after stereotactic BCBB and to examine the costs associated with this surveillance strategy. Methods: A retrospective review of women who underwent a stereotactic breast biopsy yielding benign-concordant results between January 2005 and October 2014 was performed to evaluate findings on subsequent imaging, to calculate compliance with recommended short-interval imaging, and to examine whether subsequent imaging revealed an abnormality at the site of the initial stereotactic BCBB. A cost analysis was performed utilizing Medicare reimbursement rates to calculate projected and actual costs of short-interval follow-up imaging after stereotactic BCBB. Results: Of the 470 stereotactic BCBB performed, a short-interval mammogram was completed in 207 (44.0%), 9 (4.3%) of which had suspicious mammographic findings at the initial biopsy site, and 6 subsequently underwent biopsy, with none resulting in malignant or high-risk pathology. The cost of short-interval mammographic follow-up (n = 207) was calculated at $28,541.16. Conclusions: This study provides evidence that 6-month follow-up mammography has low clinical utility and unnecessarily increases costs after stereotactic BCBB. A safe and more cost-effective strategy may be resumption of routine mammography at 12 months post-biopsy. |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mesh-Begriff(e) | Adult ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/economics ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Early Detection of Cancer/economics ; Early Detection of Cancer/statistics & numerical data ; Female ; Follow-Up Studies ; Humans ; Image-Guided Biopsy/economics ; Image-Guided Biopsy/statistics & numerical data ; Mammography/economics ; Mammography/statistics & numerical data ; Middle Aged ; Neoplasm Staging ; Prognosis ; Retrospective Studies | ||||||||||
Sprache | Englisch | ||||||||||
Erscheinungsdatum | 2018-08-23 | ||||||||||
Erscheinungsland | Netherlands | ||||||||||
Dokumenttyp | Journal Article | ||||||||||
ZDB-ID | 1143210-x | ||||||||||
ISSN | 1532-3080 ; 0960-9776 | ||||||||||
ISSN (online) | 1532-3080 | ||||||||||
ISSN | 0960-9776 | ||||||||||
DOI | 10.1016/j.breast.2018.08.101 | ||||||||||
Signatur |
|
||||||||||
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 3620: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 588: Hefte anzeigen |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.